Adial Pharmaceuticals to appoint Celia Economides as CFO
Adial Pharmaceuticals (ADIL) announced Monday that Celia Economides, the company’s current executive vice president of finance, is expected to be appointed chief financial officer, effective promptly after the company’s reconvened 2026 annual meeting of stockholders.
The company added that Economides will succeed Vinay Shah.
Before joining Adial, Economides served as chief financial officer and chief business officer of CellCentric, a clinical-stage oncology company. Before that, she served as executive vice president and chief financial officer of Gritstone Bio and later as interim chief executive officer. Earlier in her career, she held senior roles at Kezar Life Sciences and Aurinia Pharmaceuticals,.
Economides also previously served as a director of global medical affairs at BioMarin Pharmaceutical, led investor relations at the Biotechnology Innovation Organization (BIO), and worked at a healthcare-focused hedge fund and in biotech-focused financial services.
Source: press release
Recommended For You
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Register for free to keep reading.
Create a free account to get unlimited breaking news and alerts when your stocks move.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.